Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Acitretin/Cemiplimab/Fluorouracil

Lack of efficacy and generalized eruptive keratoacanthoma of Grzybowski

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kang BY, et al. Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski. Cutis 113: E8-E10, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.12788/cutis.0935 Kang BY, et al. Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski. Cutis 113: E8-E10, No. 1, Jan 2024. Available from: URL: https://dx.doi.org/10.12788/cutis.0935
Metadaten
Titel
Acitretin/Cemiplimab/Fluorouracil
Lack of efficacy and generalized eruptive keratoacanthoma of Grzybowski
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55393-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Secukinumab

Case report

Flucloxacillin

Case report

Tramadol

Case report

Multiple drugs

Case report

Cladribine